NASDAQ:XBIO
Xenetic Biosciences Inc Stock News
$3.77
-0.210 (-5.28%)
At Close: Mar 28, 2024
Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08:05am, Tuesday, 05'th Sep 2023
FRAMINGHAM, MA / ACCESSWIRE / September 5, 2023 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology tech
Xenetic Biosciences (XBIO) Reports Q2 Loss, Tops Revenue Estimates
10:47am, Friday, 11'th Aug 2023
Xenetic Biosciences (XBIO) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of $1.13. This compares to loss of $1.90 per share a year ago.
Xenetic Biosciences, Inc. to Present at the Virtual Investor NETs in Cancer Spotlight Event
08:05am, Thursday, 16'th Mar 2023
Live video webcast with moderated roundtable with members of the Xenetic leadership team and recognized oncology leader and NETs researcher, Jonathan Spicer, MD, PhD on Wednesday, March 29th at 11:00
Xenetic Biosciences, Inc. to Present at the Virtual Investor 2023 Companies to Watch Event
08:05am, Thursday, 05'th Jan 2023
Live video webcast on Tuesday, January 17th at 10:00 AM ET FRAMINGHAM, MA / ACCESSWIRE / January 5, 2023 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical com
Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference
08:05am, Wednesday, 07'th Sep 2022
FRAMINGHAM, MA / ACCESSWIRE / September 7, 2022 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology tech
Collegium Pharmaceutical (COLL) Q2 Earnings Miss Estimates
09:35pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of -90.08% and 0.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock
VolitionRx (NYSE-A:VNRX) Limited has inked a pair of research and development collaborations that will develop targeted, adoptive cell therapies to treat cancer and help advance a drug designed to t
Xenetic Biosciences, Inc. to Present at the H.C. Wainwright Global Investment Conference
08:15am, Wednesday, 18'th May 2022
Live Webcast Presentation on Wednesday, May 25th at 4:00 PM ET FRAMINGHAM, MA / ACCESSWIRE / May 18, 2022 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical co
Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
08:00am, Wednesday, 08'th Sep 2021
FRAMINGHAM, MA / ACCESSWIRE / September 8, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T
5 Penny Stocks Analysts Say To Buy With Targets Up To 300%
11:41am, Wednesday, 18'th Aug 2021
Penny stocks to buy according to analysts with price targets up to 300% right now. The post 5 Penny Stocks Analysts Say To Buy With Targets Up To 300% appeared first on Penny Stocks to Buy, Picks, New
Short Squeeze Stocks: NAOV, AHPI and 3 Others Experts Think Are Ready to Pop
03:41pm, Monday, 16'th Aug 2021
Looking for a list of the best short squeeze stocks available? We've got you covered with Fintel's insight into the topic today.
Xenetic Biosciences, Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update
08:05am, Friday, 13'th Aug 2021
Continued execution on XCART TM pre-clinical development plan and progress toward IND-enabling studies Strong royalty growth with PolyXen® platform technology Bolstered cash position with recentl
Xenetic Biosciences Shares Increase Over 37% Intraday: Why It Happened
11:52am, Thursday, 12'th Aug 2021
The shares of Xenetic Biosciences Inc (NASDAQ: XBIO) increased by over 37% during intraday trading. This is why it happened.
XBIO Stock Increased 65.11%: Details You Should Know
08:31am, Friday, 30'th Jul 2021
The stock price of Xenetic Biosciences Inc (NASDAQ: XBIO) increased by 65.11% yesterday. This is why it happened.
Xenetic Biosciences, Inc. Announces Closing of $12.5 Million Private Placement Priced at a Premium to Market
02:00pm, Wednesday, 28'th Jul 2021
FRAMINGHAM, MA / ACCESSWIRE / July 28, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T plat